Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss [Phase 3]
Phase 3 trial assessing efficacy and safety of clascoterone solution for male pattern hair loss (androgenetic alopecia) has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Clinical Study of PRP in the Treatment of Androgenetic Alopecia [NA]
A clinical trial evaluating platelet-rich plasma for androgenetic alopecia has completed.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia [NA]
This clinical trial compares VENEZE Peptide Factor Hair Serum with 2% topical minoxidil for androgenetic alopecia and is currently not recru…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study [Phase 2]
This clinical trial is Phase 2 evaluating platelet-rich plasma (PRP) combined with Botulinum toxin type A injections for androgenetic alopec…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. [Phase 3]
Phase 3 study evaluating the efficacy and safety of an oral minoxidil formulation (N1087) in men with androgenetic alopecia; study status is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia [Phase 3]
Phase 3 clinical trial update for APSMNF in male androgenetic alopecia, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Effect of Nanofat Injection on Androgenetic Alopecia [Phase 4]
A Phase 4 clinical trial update on nanofat injections for androgenetic alopecia, with recruitment not yet started.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth [Phase 2, Phase 3]
This clinical trial update indicates that DA-001 is being studied in Phase 2/3 for reducing hair shedding and promoting hair regrowth, with …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia [NA]
A clinical trial compares topical 2-Deoxy-D-ribose hydrogel to minoxidil 5% solution for androgenetic alopecia. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia [Phase 2]
Phase 2 clinical trial evaluating topical Lactobacillus reuteri for androgenetic alopecia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing a topical dutasteride formulation for male androgenetic alopecia; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study
A training and validation study to develop an artificial intelligence tool for diagnosing androgenetic alopecia, with the trial status not y…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: XVIE to Treat Androgenetic Alopecia (AGA) [Phase 1, Phase 2]
A clinical trial update indicates XVIE is planned for Phase 1/2 testing to treat androgenetic alopecia, with recruitment not yet started.
-
FDA approval · 2026-03-18FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROSCAR (finasteride) submitted by Organon LLC.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss [Phase 3]
A Phase 3 study evaluating the efficacy and safety of clascoterone solution for male pattern hair loss (androgenetic alopecia) is active but…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating the safety and efficacy of OLX72021 in healthy males with androgenetic alopecia,…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of 5% minoxidil topical foam in women with androgenetic alopecia is currently re…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia [Phase 2]
A Phase 2 clinical trial evaluating CG2001 for androgenetic alopecia in Chinese adult male participants has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.
The clinical trial evaluating a shampoo for hair loss in telogen effluvium and androgenetic alopecia has completed.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients [Phase 1, Phase 2]
The document outlines a Phase 1/2 clinical trial comparing secretome injections to platelet-rich plasma injections for improving hair densit…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Therapeutic Potential of Topical Latanoprost Acid in Hair Loss - Pilot, Proof-of-concept Study [NA]
A completed pilot, proof-of-concept trial evaluated topical latanoprost acid as a potential treatment for hair loss. The study focused on an…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Safety and Efficacy of VDPHL01 in Males With AGA [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of VDPHL01 for androgenetic alopecia in males; the study is currently active but n…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) [NA]
ClinicalTrials.gov entry for a single-site study evaluating autologous hair follicle secretome as a treatment for androgenetic alopecia; rec…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in Subjects With Mild to Moderate Hair Thinning. [NA]
This clinical trial update notes a study evaluating a Hair Growth and Scalp Health Serum in adults with mild to moderate hair thinning. The …
-
FDA approval · 2026-01-26FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Finasteride submitted by Teva Pharmaceuticals USA, Inc.